Publicação
Opioid detection and quantification in plasma and oral fluid by LC-MS/MS.
| dc.contributor.author | Rosendo, Luana M | |
| dc.contributor.author | Costa, Suzel | |
| dc.contributor.author | Simões, Susana | |
| dc.contributor.author | Franco, João | |
| dc.contributor.author | Serrano Gadea, Noelia | |
| dc.contributor.author | Escorial, Mónica | |
| dc.contributor.author | Toboso Ortega, Francisco Javier | |
| dc.contributor.author | Jiménez-García, Segundo | |
| dc.contributor.author | Peiró, Ana M | |
| dc.contributor.author | Duque, Isabel | |
| dc.contributor.author | Rosado, Tiago | |
| dc.contributor.author | Barroso, Mário | |
| dc.contributor.author | Gallardo, Eugenia | |
| dc.date.accessioned | 2026-02-03T09:25:27Z | |
| dc.date.available | 2026-02-03T09:25:27Z | |
| dc.date.issued | 2026-01-28 | |
| dc.description.abstract | The opioid crisis remains a significant public health concern, necessitating the development of sensitive and reliable analytical methods for drug detection. This study aimed to develop and validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous detection and quantification of fentanyl, buprenorphine, oxycodone, morphine, tramadol, and tapentadol in plasma and oral fluid. The method was validated according to FDA guidelines, assessing selectivity, linearity, precision, accuracy, matrix effect, extraction efficiency, stability, carryover, and dilution integrity. The lower limits of quantification (LLOQs) were established at 0.1 ng/mL for fentanyl, 1.2 ng/mL for tramadol, and 0.6 ng/mL for the remaining opioids, demonstrating high sensitivity. The method exhibited excellent precision and accuracy, with coefficients of variation below 15% for intra-day, inter-day, and intermediate precision analyses. Extraction efficiencies exceeded 90% for most analytes, and matrix effects remained within acceptable limits. Real-world application to authentic plasma and oral fluid samples confirmed the method's robustness and reliability. Oral fluid concentrations were detectable across all target opioids, although plasma-oral fluid ratios showed some compound-dependent variability. These findings highlight the potential of oral fluid as a non-invasive complementary matrix to plasma for opioid monitoring, with relevant implications for forensic toxicology and clinical drug monitoring. | eng |
| dc.description.sponsorship | This study was also supported by the National Drug Plan Budget from the Spanish Ministry of Health MORPHEO 2024–01), and through the UniSalut joint collaboration between Universitat Politècnica de València (UPV, POLISABIO App-DEPOP-SOFT 2024-PI1), Universidad Miguel Hernández (UMH, ILISABIO AppDEPOP 2023-AP08), and FISABIO. | |
| dc.identifier.citation | Rosendo, L. M., Costa, S., Simões, S., Franco, J. M., Serrano Gadea, N., Escorial, M., Toboso Ortega, F. J., Jiménez-García, S., Peiró, A. M., Duque, I., Rosado, T., Barroso, M., & Gallardo, E. (2026). Opioid detection and quantification in plasma and oral fluid by LC-MS/MS. Analytical and bioanalytical chemistry, (2026) Advance online | |
| dc.identifier.doi | 10.1007/s00216-026-06336-1 | |
| dc.identifier.issn | 1618-2642 | |
| dc.identifier.uri | http://hdl.handle.net/10400.26/61391 | |
| dc.language.iso | en | |
| dc.peerreviewed | yes | |
| dc.publisher | Springer | |
| dc.relation | Health Sciences Research Centre | |
| dc.relation | Health Sciences Research Centre | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | LC–MS/MS | |
| dc.subject | Opioids | |
| dc.subject | Oral fluid | |
| dc.subject | Plasma | |
| dc.title | Opioid detection and quantification in plasma and oral fluid by LC-MS/MS. | eng |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.awardTitle | Health Sciences Research Centre | |
| oaire.awardTitle | Health Sciences Research Centre | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00709%2F2020/PT | |
| oaire.awardURI | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00709%2F2020/PT | |
| oaire.citation.title | Analytical and bioanalytical chemistry | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.fundingStream | 6817 - DCRRNI ID | |
| oaire.version | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |
| person.familyName | Costa | |
| person.familyName | Simões | |
| person.familyName | Franco | |
| person.familyName | Barroso | |
| person.givenName | Suzel | |
| person.givenName | Susana | |
| person.givenName | João | |
| person.givenName | Mário | |
| person.identifier.ciencia-id | F611-6D58-E4C2 | |
| person.identifier.ciencia-id | 5110-F476-ECCC | |
| person.identifier.orcid | 0009-0002-1268-8052 | |
| person.identifier.orcid | 0000-0002-9457-1546 | |
| person.identifier.orcid | 0000-0002-3268-3841 | |
| person.identifier.orcid | 0000-0001-8848-2734 | |
| person.identifier.scopus-author-id | 35329243100 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.identifier | http://doi.org/10.13039/501100001871 | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| project.funder.name | Fundação para a Ciência e a Tecnologia | |
| relation.isAuthorOfPublication | 8592c807-a8a5-4408-90d5-b32ceaf6b363 | |
| relation.isAuthorOfPublication | d0a1e3e3-4d0e-49b5-804e-a55e700f8d22 | |
| relation.isAuthorOfPublication | 045c4125-1313-445f-b05f-b7f204886052 | |
| relation.isAuthorOfPublication | 294b555e-48c4-4013-b981-b8917400c56c | |
| relation.isAuthorOfPublication.latestForDiscovery | 8592c807-a8a5-4408-90d5-b32ceaf6b363 | |
| relation.isProjectOfPublication | 4ca3c3c9-1802-4c7f-8730-9547236896fe | |
| relation.isProjectOfPublication | 56ce2e5c-35e5-4eb7-8152-2e87e77f638c | |
| relation.isProjectOfPublication.latestForDiscovery | 4ca3c3c9-1802-4c7f-8730-9547236896fe |
